ValityX Revenue and Competitors
Estimated Revenue & Valuation
- ValityX's estimated annual revenue is currently $362.5k per year.
- ValityX's estimated revenue per employee is $72,500
Employee Data
- ValityX has 5 Employees.
- ValityX grew their employee count by -17% last year.
ValityX's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
ValityX Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.1M | 6 | 0% | $15.5M | N/A |
#2 | $14.9M | 103 | -1% | N/A | N/A |
#3 | $339.8M | 1639 | -20% | N/A | N/A |
#4 | $125.8M | 694 | -15% | N/A | N/A |
#5 | $112.4M | 620 | 2% | N/A | N/A |
#6 | $33.4M | 214 | -23% | $21.1M | N/A |
#7 | $23.2M | 149 | -12% | $21.7M | N/A |
#8 | $43.1M | 270 | -10% | N/A | N/A |
#9 | $32.7M | 205 | -10% | N/A | N/A |
#10 | $26.3M | 165 | -35% | N/A | N/A |
What Is ValityX?
ValityX is a privately held service firm focused on data analytics. We work with both start-up and established companies who desire to use data analytics to create value for their organizations. If your challenge is technical support for a big data project, business strategy around using data, or simply how can you use analytics to improve your organization, we can help. We sell services to the federal government and commercial markets. The company has proven expertise in Information Technology services, with a particular emphasis on healthcare (specifically our focus is on commercial healthcare providers, Military Health, Veterans Affairs, and Health & Human Services). We are based in the Washington, DC metro area and work nationally.
keywords:N/AN/A
Total Funding
5
Number of Employees
$362.5k
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 5 | 0% | N/A |
#2 | $0.4M | 5 | 0% | N/A |
#3 | $0.4M | 5 | -29% | N/A |
#4 | $0.4M | 5 | 0% | N/A |
#5 | $0.4M | 5 | -17% | N/A |